Methylprednisolone (MP)

DRUG6 trials

Conditions

Acute Respiratory Distress SyndromeAntibody-Mediated Rejection (AMR)Antibody-mediated RejectionBone Marrow FailureDyskeratosis CongenitaFanconi AnemiaMACEMortality

Phase 2

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

RecruitingNCT03579875

Masonic Cancer Center, University of MinnesotaBone Marrow Failure, Dyskeratosis Congenita, Fanconi Anemia +5

Start: 2018-11-13End: 2029-01-05Target: 48Updated: 2026-01-30

Corticosteroids in Hyperinflammatory Phenotype of Critical Illness

RecruitingNCT07511582

Bin DuAcute Respiratory Distress Syndrome, Sepsis

Start: 2026-04-15End: 2028-06-01Target: 150Updated: 2026-05-26

Sequential Daratumumab Followed by Telitacicept for the Treatment of ABMR After Kidney Transplantation-A Phase IIa Clinical Trial

Active, not recruitingNCT07902609

First Affiliated Hospital, Sun Yat-Sen UniversityAntibody-mediated Rejection, Antibody-Mediated Rejection (AMR)

Start: 2026-06-20End: 2028-06-30Target: 20Updated: 2026-10-29

Phase 4

Methylprednisolone for Moderate to Severe Traumatic Brain Injury

RecruitingNCT07180277

Zhangjiagang First People's HospitalTraumatic Brain Injury

Start: 2026-03-29End: 2029-07-31Target: 520Updated: 2026-09-22

Unknown Phase

Methylprednisolone vs Dexamethasone: Effects on Sugammadex Reversal, Pain, and Nausea in Adults

Not yet recruitingNCT07187037

Konya City HospitalNeuromuscular Block, Residual, Pain, Postoperative Nausea

Start: 2025-10-01End: 2026-04-30Target: 130Updated: 2025-09-22

Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome

Not yet recruitingNCT07328906

University of BelgradeMACE, Mortality, Myocardial Injury +1

Start: 2026-01-31End: 2029-01-31Target: 174Updated: 2026-01-12

Related Papers

TCRα/β Depleted Mobilized Pbscs without Calcineurin Inhibitors in Patients with Fanconi Anemia

Blood2024-11-05

Methylprednisolone (MP)

Sponsors

Conditions

Phase 2

Phase 4

Unknown Phase

Related Papers